Cargando…

Zidovudine (AZT) Monotherapy Selects for the A360V Mutation in the Connection Domain of HIV-1 Reverse Transcriptase

BACKGROUND: We previously demonstrated in vitro that zidovudine (AZT) selects for A371V in the connection domain and Q509L in ribonuclease H (RNase H) domain of HIV-1 reverse transcriptase (RT) which, together with the thymidine analog mutations D67N, K70R and T215F, confer greater than 100-fold AZT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brehm, Jessica H., Scott, Yanille, Koontz, Dianna L., Perry, Steven, Hammer, Scott, Katzenstein, David, Mellors, John W., Sluis-Cremer, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283647/ https://www.ncbi.nlm.nih.gov/pubmed/22363673 http://dx.doi.org/10.1371/journal.pone.0031558

Ejemplares similares

N348I in the Connection Domain of HIV-1 Reverse Transcriptase Confers Zidovudine and Nevirapine Resistance
por: Yap, Soo-Huey, et al.
Publicado: (2007)

Teratogenic and Embryocidal Effects of Zidovudine (AZT) in Sprague-Dawley Rats
por: Christmas, James T., et al.
Publicado: (1995)

Structures of Reverse Transcriptase Pre- and Post-Excision Complexes Shed New Light on HIV-1 AZT Resistance
por: Scott, Walter A.
Publicado: (2011)

Zidovudine (AZT) and Hepatic Lipid Accumulation: Implication of Inflammation, Oxidative and Endoplasmic Reticulum Stress Mediators
por: Banerjee, Atrayee, et al.
Publicado: (2013)

AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP
por: Hartl, Maximilian J., et al.
Publicado: (2008)

AZT resistance alters enzymatic properties and creates an ATP-binding site in SFVmac reverse transcriptase
por: Schneider, Anna, et al.
Publicado: (2015)

The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors
por: Sluis-Cremer, Nicolas
Publicado: (2014)

First line treatment of acute and chronic ATLL with zidovudine (AZT) and interferon alpha (IFN-α): haematological and molecular responses
por: Hodson, Andrew, et al.
Publicado: (2011)

A Single Zidovudine (AZT) Administration Delays Hepatic Cell Proliferation by Altering Oxidative State in the Regenerating Rat Liver
por: Butanda-Ochoa, Armando, et al.
Publicado: (2017)

Subunit-specific mutational analysis of residue N348 in HIV-1 reverse transcriptase
por: Radzio, Jessica, et al.
Publicado: (2011)

Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
por: Schauer, Grant, et al.
Publicado: (2013)

Large Multidomain Protein NMR: HIV-1 Reverse Transcriptase Precursor in Solution
por: Ilina, Tatiana V., et al.
Publicado: (2020)

Potent Nonnucleoside Reverse Transcriptase Inhibitors Target HIV-1 Gag-Pol
por: Figueiredo, Anna, et al.
Publicado: (2006)

Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence
por: Schauer, Grant D., et al.
Publicado: (2014)

Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains
por: Yu, Fei, et al.
Publicado: (2018)

Substrate mimicry: HIV-1 reverse transcriptase recognizes 6-modified-3′-azido-2′,3′-dideoxyguanosine-5′-triphosphates as adenosine analogs
por: Herman, Brian D., et al.
Publicado: (2012)

Zidovudine.
por: Sperling, R
Publicado: (1998)

AZT as a telomerase inhibitor
por: Gomez, Daniel E., et al.
Publicado: (2012)

Human adenovirus DNA polymerase is evolutionarily and functionally associated with human telomerase reverse transcriptase based on in silico molecular characterization that implicate abacavir and zidovudine
por: Fatoki, Toluwase Hezekiah
Publicado: (2023)

Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors
por: Schneider, Anna, et al.
Publicado: (2016)

The RNA binding protein HuR does not interact directly with HIV-1 reverse transcriptase and does not affect reverse transcription in vitro
por: Ahn, Jinwoo, et al.
Publicado: (2010)

Zidovudine-induced reversible pure red cell aplasia
por: Balakrishnan, Anuja, et al.
Publicado: (2010)

Neurotoxic effects of AZT on developing and adult neurogenesis
por: Demir, Meryem, et al.
Publicado: (2015)

Quercetin attenuates AZT-induced neuroinflammation in the CNS
por: Yang, Yi, et al.
Publicado: (2018)

Targeting HIV-1 Reverse Transcriptase Using a Fragment-Based Approach
por: Mansouri, Mahta, et al.
Publicado: (2023)

Zidovudine-induced myopathy
por: Wiwanitkit, Viroj
Publicado: (2011)

Zidovudine Induced Hyperpigmentation
por: Premjith, Raveendran, et al.
Publicado: (2022)

THU360 Hyperglycemic DKA In Patient On Monotherapy With SGLT-2 Inhibitor
por: Ahmed, Samihah, et al.
Publicado: (2023)

The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance
por: Acosta-Hoyos, Antonio J., et al.
Publicado: (2010)

In Vitro HIV-1 Evolution in Response to Triple Reverse Transcriptase Inhibitors & In Silico Phenotypic Analysis
por: Rath, Barbara A., et al.
Publicado: (2013)

Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women
por: Huntington, Susie, et al.
Publicado: (2014)

Utilization of a Deoxynucleoside Diphosphate Substrate by HIV Reverse Transcriptase
por: Garforth, Scott J., et al.
Publicado: (2008)

A reverse transcriptase ribozyme
por: Samanta, Biswajit, et al.
Publicado: (2017)

Connection Domain Mutations N348I and A360V in HIV-1 Reverse Transcriptase Enhance Resistance to 3′-Azido-3′-deoxythymidine through Both RNase H-dependent and -independent Mechanisms
por: Ehteshami, Maryam, et al.
Publicado: (2008)

Chemical and chemoenzymatic routes to bridged homoarabinofuranosylpyrimidines: Bicyclic AZT analogues
por: Kumar, Sandeep, et al.
Publicado: (2022)

Reverse transcriptase activity in psoriatic lesions: effects of reverse transcriptase inhibitors on keratinocyte proliferation and differentiation
por: Molès, Jean-Pierre, et al.
Publicado: (2009)

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2019)

Placental Transport of Zidovudine in the Rhesus Monkey
por: Ridgway III, Louis E., et al.
Publicado: (1993)

Targeting the Structural Maturation Pathway of HIV-1 Reverse Transcriptase
por: Kirby, Thomas W., et al.
Publicado: (2023)

Inhibition of ATL development in humanized mouse model by AZT/INF treatment
por: Tezuka, Kenta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ocel2bm40smj4r0v7p8jk280vj